REBECCA CHARPENTIER: Open Payments
NPI 1679290159 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,221 in 70 payments from 15 companies in 2025. Trend: 2023 $1,035 · 2024 $950 · 2025 $1,221
Food & beverage: $1,221
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $237 |
| UCB, Inc. | 7 | $233 |
| Forte Bio-Pharma LLC | 12 | $206 |
| PFIZER INC. | 6 | $161 |
| Neurelis, Inc. | 4 | $91 |
| ACADIA Pharmaceuticals Inc | 3 | $72 |
| Biogen, Inc. | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Eisai Inc. | 1 | $22 |
| Aucta Pharmaceuticals, Inc. | 1 | $21 |
Products named: TANLOR, Nayzilam, UBRELVY, ZAVZPRET, QULIPTA, VALTOCO, Fintepla, SKYCLARYS.
Industry payments across GA — which companies pay providers there.
